成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 58-85-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 58-85-5
Chemical Structure| 58-85-5
Structure of 58-85-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 58-85-5 ]

Related Doc. of [ 58-85-5 ]

Alternatived Products of [ 58-85-5 ]
Product Citations

Product Citations

Mokhtarpour, Nazanin ; Sterling, Alyssa ; Garcia, Joshua J. , et al. DOI: PubMed ID:

Abstract: Reactive oxygen species (ROS) are a heterogeneous group of highly reactive ions and mols. derived from mol. oxygen (O2) which can cause DNA damage and lead to skin cancer. NADPH oxidase 1 (Nox1) is a major producer of ROS in the skin upon exposure to UV light. Functionally, Nox1 forms a holoenzyme complex that generates two superoxide mols. and reduces NADPH. The signaling activation occurs when the organizer subunit Noxo1 translocates to the plasma membrane bringing a cytochrome P 450, through interaction with Cyba. We propose to design inhibitors that prevent Cyba-Noxo1 binding as a topical application to reduce UV-generated ROS in human skin cells. Design started from an apocynin backbone structure to generate a small mol. to serve as an anchor point. The initial compound was then modified by addition of a polyethylene glycol linked biotin. Both inhibitors were found to be non-toxic in human keratinocyte cells. Further in vitro experiments using isothermal calorimetric binding quantification showed the modified biotinylated compound bound Noxo1 peptide with a KD of 2 nM. Both using isothermal calorimetric binding and MALDI (TOF) MS showed that binding of a Cyba peptide to Noxo1 was blocked. In vivo experiments were performed using donated skin explants with topical application of the two inhibitors. Experiments show that UV light exposure of with the lead compound was able to reduce the amount of cyclobutene pyrimidine dimers in DNA, a mol. known to lead to carcinogenesis. Further synthesis showed that the polyethylene glycol but not the biotin was essential for inhibition.

Keywords: Reactive oxygen species ; Apocynin ; UV ; Noxo1 ; Cyba ; Cyclobutane pyrimidine dimer ; CPD ; UV protection

Purchased from AmBeed: ; ; ; ; ;

Product Details of [ 58-85-5 ]

CAS No. :58-85-5 MDL No. :MFCD00005541
Formula : C10H16N2O3S Boiling Point : -
Linear Structure Formula :HO2C(CH2)4CHSCH2CHNHC(O)NHCH InChI Key :YBJHBAHKTGYVGT-ZKWXMUAHSA-N
M.W : 244.31 Pubchem ID :171548
Synonyms :
D-Biotin;Vitamin B7;D-Biotin, Vitamin B7;NSC 63865;Vitamin H
Chemical Name :5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid

Calculated chemistry of [ 58-85-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 3.0
Molar Refractivity : 69.34
TPSA : 103.73 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.56 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.17
Log Po/w (XLOGP3) : 0.33
Log Po/w (WLOGP) : 0.04
Log Po/w (MLOGP) : 0.74
Log Po/w (SILICOS-IT) : 0.66
Consensus Log Po/w : 0.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.23
Solubility : 14.3 mg/ml ; 0.0585 mol/l
Class : Very soluble
Log S (Ali) : -2.07
Solubility : 2.07 mg/ml ; 0.00847 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.67
Solubility : 5.2 mg/ml ; 0.0213 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.38

Safety of [ 58-85-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 58-85-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 58-85-5 ]
  • Downstream synthetic route of [ 58-85-5 ]

[ 58-85-5 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 100-02-7 ]
  • [ 58-85-5 ]
  • [ 33755-53-2 ]
Reference: [1] Bioconjugate Chemistry, 2017, vol. 28, # 4, p. 913 - 917
  • 2
  • [ 58-85-5 ]
  • [ 33755-53-2 ]
Reference: [1] Journal of the American Chemical Society, 1977, vol. 99, # 1, p. 235 - 239
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;